Five notes about the company’s second quarter performance:
1. Net sales were $2 billion, up 60.7 percent.
2. Spine and dental sales were $263.5 million, up 73.1 percent from the same time last year.
3. Knee sales were up 77.5 percent at $665.6 million net sales. Hip sales also increased 44 percent globally with $474.6 million net sales.
4. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were up 57.9 percent at $462.1 million.
5. The company updated its projected ranges for revenue growth and expects to see a 14.5 percent to 16.5 percent increase by the end of the year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
